B
Björn Wettermark
Researcher at Karolinska Institutet
Publications - 210
Citations - 8470
Björn Wettermark is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Population & Health care. The author has an hindex of 47, co-authored 185 publications receiving 7347 citations. Previous affiliations of Björn Wettermark include Karolinska University Hospital & Uppsala University.
Papers
More filters
Journal ArticleDOI
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
Björn Wettermark,Björn Wettermark,Niklas Hammar,Niklas Hammar,C. MichaelFored,Andrejs Leimanis,Petra Otterblad Olausson,Ulf Bergman,Ingemar Persson,Ingemar Persson,Anders Sundström,Barbro Westerholm,Måns Rosén +12 more
TL;DR: The content and potentials of the new Swedish national register on prescribed and dispensed medicines are described.
Journal ArticleDOI
The Nordic countries as a cohort for pharmacoepidemiological research.
Kari Furu,Björn Wettermark,Morten Andersen,Jaana E. Martikainen,Anna Birna Almarsdóttir,Henrik Toft Sørensen +5 more
TL;DR: An overview of the prescription databases established in the Nordic countries is presented, as well as to elaborate on their unique potential for record linkage and cross-national comparison of drug utilization, to assist in resolving safety issues of international interest.
Journal ArticleDOI
The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden
Ramin Zarrinkoub,Ramin Zarrinkoub,Björn Wettermark,Björn Wettermark,Per Wändell,Märit Mejhert,Robert Szulkin,Gunnar Ljunggren,Gunnar Ljunggren,Thomas Kahan +9 more
TL;DR: The current prevalence, incidence, mortality, and 5‐year survival rate of CHF, and possible temporal changes in Sweden are determined.
Journal ArticleDOI
The 'Wise List' - A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
Lars L. Gustafsson,Björn Wettermark,Björn Wettermark,Brian Godman,Eva Andersén-Karlsson,Ulf Bergman,Jan Hasselström,Lars-Olof Hensjö,Paul Hjemdahl,Ingrid Jägre,Margaretha Julander,Bo Ringertz,Daniel Schmidt,Susan Sjöberg,Folke Sjöqvist,Carl-Olav Stiller,Elisabeth Törnqvist,Rolf Tryselius,Sigurd Vitols,Christer von Bahr +19 more
TL;DR: The acceptance of the 'Wise List' in terms of trust among physicians and among the public and increased adherence may be explained by clear criteria for drug recommendations, a comprehensive communication strategy, electronic access to recommendations, continuous medical education and involvement of professional networks and patients.
Journal ArticleDOI
Drug utilization 90%--a simple method for assessing the quality of drug prescribing.
TL;DR: The idea that the number of drugs accounting for 90% of drug use – drug utilization 90% (DU90%) – may serve as an indicator of the quality of drug prescribing in routine health care is tested.